![Ayman El-Guindy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ayman El-Guindy is currently the Chief Scientific Officer at Viracta Therapeutics, Inc. Previously, he worked as an Associate Professor at Yale School of Medicine.
He received his graduate and doctorate degrees from Yale University and his graduate degree from Ain Shams University.
| Sociétés | Poste | Début |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ain Shams University
 Ain Shams University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
